J2P-MC-LXBD app for iPhone and iPad

4.4 ( 6624 ratings )

Health & Fitness Medical
Developer: Medable, Inc.

Free

Current version: 1.1, last update: 4 months ago
First release : 20 Sep 2023
App size: 86.7 Mb

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain